The results of the clinical study carried out by Alyatec for the American laboratory Regeneron Pharmaceuticals will be presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (official website).
The 2021 edition of this internationally renowned congress will be entirely virtual and will take place from February 26th to March 1st.
The mentionned study is a phase 2 designed to assess the efficacy of a drug candidate intended for asthmatic people allergic to cats.
More information on this study can be found here.
We will share more details about this presentation during February!
